The Magazine for Sleep Professionals
Sunday, September 13, 2026
The U.S. Food and Drug Administration (FDA) is alerting patients, caregivers, and health care providers that Philips Respironics (Philips) recalled certain masks used with bilevel positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines and continuous positive airway pressure (CPAP) machines due to a serious safety concern. The […]
The U.S. Food and Drug Administration (FDA) is alerting patients, caregivers, and health care providers that Philips Respironics (Philips) recalled certain bi-level positive airway pressure (also known as Bilevel PAP, BiPAP, or BPAP) machines that may contain a plastic contaminated with a non-compatible material. If that plastic is in the […]
Respironics Inc. has agreed to pay over $24 million to resolve False Claims Act allegations that it misled federal health care programs by paying kickbacks to DME suppliers. The affected programs were Medicare, Medicaid and TRICARE, which is the health care program for active military and their families. The settlement […]
Royal Philips introduced DreamWear Silicone Pillows to the innovative DreamWear system of masks in North America. The all-silicone pillow cushion was designed using data from thousands of 3D facial scans to anatomically conform to fit and seal various nostril shapes and sizes across populations. Aiming to address mask refit and therapy adherence […]
Royal Philips has announced the launch of the Philips Respironics Mask Selector, the first and only clinically validated, 3D facial scanning solution that helps providers to fit 9 out of 10 patients with the right mask from the start [1]. The proprietary Mask Selector algorithm offers a novel solution in the […]
New DreamStation Go Heated Humidifier, DreamWisp mask and recent resupply integration offers efficient and effective care options for HMEs and their patients Royal Philips showcased its commitment to helping home medical equipment partners succeed by introducing new solutions and services at Medtrade Spring 2019. During the show, Philips featured its latest […]
COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20-39 percent1-3, with related healthcare costs at an estimated $50 billion4-5. A recently published study, funded by Royal Philips (NYSE: PHG, AEX: PHIA), revealed that although positive airway pressure (PAP) therapy was associated with a […]
